December 3, 2010 -- C&O Pharmaceutical Technology Holdings Limited, a diversified China pharma that is listed on the Singapore exchange, said Sumitomo Corporation has bought a 29% stake in the company, paying $73 million. Sumitomo purchased the shares from a corporation owned by C&O’s Executive Chairman, Gao Bin. More details...
